Intent to Sole Source-Labcyte, Inc.
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Centers for Disease Control and Prevention (CDC) plans to award a sole source, firm-fixed-price contract to Labcyte, Inc., located in Sunnyvale, California, to procure the Echo 550 acoustic liquid handling instrument. This specialized equipment is intended for testing compounds to identify antiviral activities against highly pathogenic viruses. Labcyte is the exclusive manufacturer of the Echo 550 ScrnOmics system, justifying the sole source procurement under the applicable federal acquisition regulations. The contract falls under the authority allowing negotiation with a single source due to the unique nature of the product. Although this notice is not a solicitation for competitive quotations, the CDC invites interested parties to express their interest or submit proposals by May 3, 2016, for consideration in determining whether a competitive process is warranted. All communications must be made in writing and directed to the designated contact via email; telephone inquiries will not be accepted. The outcome of this notice remains at the full discretion of the Government.
General Info
Agency
Place of Performance
Not specifiedSet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
